(Reuters) - The biopharmaceutical company said the offering was increased from the previous 9.5 million shares announced on July 9.
Dyax said it plans to give underwriters a 30-day option to buy up to about 1.6 million shares at the public offer price to cover over-allotments, if any.
Read more at Reuters.com Government Filings News
Dyax said it plans to give underwriters a 30-day option to buy up to about 1.6 million shares at the public offer price to cover over-allotments, if any.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment